High Incidence of Type 2 Diabetes in Peroxisome Proliferator–Activated Receptor γ2 Pro12Ala Carriers Exposed to a High Chronic Intake of Trans Fatty Acids and Saturated Fatty Acids
- 1 September 2004
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (9) , 2251-2252
- https://doi.org/10.2337/diacare.27.9.2251
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2004
- Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor γ (PPARγ) gene and type 2 diabetesExperimental and Clinical Endocrinology & Diabetes, 2001
- Evidence for Gene-Nutrient Interaction at the PPARγ LocusDiabetes, 2001
- The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetesNature Genetics, 2000
- Peroxisome Proliferator-Activated Receptor-γ2 P12A and Type 2 Diabetes in Canadian Oji-Cree*Journal of Clinical Endocrinology & Metabolism, 2000
- Peroxisome Proliferator-Activated Receptor- 2 P12A and Type 2 Diabetes in Canadian Oji-CreeJournal of Clinical Endocrinology & Metabolism, 2000
- Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.Diabetes, 1999
- Introduction to a Collection of Physical Activity QuestionnairesMedicine & Science in Sports & Exercise, 1997